China Pharma Holdings, Inc. (CPHI) Reports Q3 Loss of $0.04
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/28/2026
- Wall St slips as oil spikes after Trump rejects Iran peace proposal
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
- Nvidia’s AI dominance funds historic $150 billion buyback
- MongoDB stock drops 15% as CEO Desai resigns for Meta
- Jefferies cuts Roblox to Underperform, says rally is too optimistic
- Bloom Energy shares fall on Oracle project halt
- Oppenheimer sees AI software winners as focus shifts to ROI
- Exclusive-Activist Jana pushes Fiserv to accelerate cost cuts and tap Palantir
- Cantor Fitzgerald Starts Lexicon Pharmaceuticals (LXRX) at Overweight
- Arm Holdings falls as CFO stock sale weighs on sentiment
China Pharma Holdings, Inc. Reports Third Quarter 2018 Financial Results
November 15, 2018 6:00 AM ESTHAIKOU CITY, China, Nov. 15, 2018 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE MKT: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, announced today its financial results for the quarter ended September 30, 2018.
Third Quarter Highlights
Revenue was $2.3 million for the three months ended September 30, 2018, which represented a decrease of 27.3% compared to $3.2 million for the three months ended September 30, 2017; Gross profit was $0.5 million and $0.4 million for the three months ended September 30, 2018 and 2017, respectively.... More